Help With Success In Health Wealth And Relationships
New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study, published Wednesday in the New England Journal of Medicine, included 800 adults with a severe form of liver disease known as metabolic dysfunction-associated steatohepatitis, or MASH. People develop MASH after fat builds up in […]
Continue Reading
At least once a week, someone asks Dr. Skyler Johnson if ivermectin can treat their cancer. Patients have asked about the anti-parasitic drug for years, especially during the pandemic. But in recent months, Dr. Johnson, a radiation oncologist at the University of Utah Huntsman Cancer Institute, has fielded more and more questions about the medication. […]
Continue ReadingOver a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice. Now, as the next generation of these medications has soared in popularity, and scientists discover they may have wide-ranging health benefits, research is revving up to […]
Continue Reading | Priority Search Engine Submissions |
| 48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com! |
Over the last three years, a new class of Alzheimer’s drug, the first to treat a root cause of the disease, has set off a roller coaster of hope and disappointment. But while these so-called anti-amyloid antibodies had a rough start, many patients and their doctors are feeling more optimistic now that one of the […]
Continue ReadingNews around drugs like Ozempic moves fast: There’s a steady drumbeat of new studies, new regulatory approvals, new shortages, new insurance hurdles. Here’s a primer on Ozempic and other popular drugs being widely used for diabetes and weight loss. How do drugs like Ozempic work? Ozempic belongs to a class of medications called GLP-1 receptor […]
Continue Reading | Priority Search Engine Submissions |
| 48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com! |
In the mid-1990s, Carlos Monteiro, a nutritional epidemiologist in Brazil, noticed something alarming: Obesity rates among children in his country were rising rapidly. To understand why, he and his colleagues at the University of São Paulo scrutinized data on the food buying patterns of Brazilian households to see if they had changed in recent years. […]
Continue Reading
Five years ago, the National Institutes of Health abruptly pulled the plug on an ambitious study about the health effects of moderate drinking. The reason: The trial’s principal scientist and officials from the federal agency’s own alcohol division had solicited $60 million for the research from alcohol manufacturers, a conflict of interest and a violation […]
Continue Reading | Priority Search Engine Submissions |
| 48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com! |
Why It Matters: Gonorrhea is a major global problem. With more than 82 million new infections recorded worldwide in 2020, gonorrhea is among the most common sexually transmitted diseases. The pathogen, Neisseria gonorrhoeae, spreads through sexual contact to the genitals, rectum and throat. About half of infected people show no symptoms, but in others gonorrhea […]
Continue Reading
As we approach winter virus season, some people may be looking for additional protection against contracting Covid-19 beyond receiving the updated vaccine and wearing a mask. In theory, nasal sprays could be one way to do that, offering an extra layer of defense precisely where the virus enters the body. Ideally, you could use a […]
Continue Reading
Every so often a drug comes along that has the potential to change the world. Medical specialists say the latest to offer that possibility are the new drugs that treat obesity — Ozempic, Wegovy, Mounjaro and more that may soon be coming onto the market. It’s early, but nothing like these drugs has existed before. […]
Continue ReadingThe Food and Drug Administration on Friday approved the first pill for postpartum depression, a milestone considered likely to increase recognition and treatment of a debilitating condition that afflicts about a half-million women in the United States every year. Clinical trial data show the pill works quickly, beginning to ease depression in as little as […]
Continue Reading
Ozempic and Wegovy have already changed the landscape for obesity in America — a breakthrough that has been described and debated so much in terms of cosmetic benefits and medical moral hazard that it can be easy to forget that obesity is among the largest risk factors for preventable death in the United States. Next-generation […]
Continue Reading